Sarepta Therapeutics Inc. logo

Sarepta Therapeutics Inc. (SRPT)

Market Open
20 Jul, 18:09
NASDAQ (NGS) NASDAQ (NGS)
$
17. 18
-0.04
-0.2613%
$
1.9B Market Cap
- P/E Ratio
- Div Yield
826,283 Volume
-6.99 Eps
$ 17.22
Previous Close
Add Transaction
Day Range
16.95 17.39
Year Range
10.42 25.32
Want to track SRPT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Sarepta Therapeutics Inc. (SRPT) Statistics

Valuation metrics

Market Cap 1.9B
Enterprise value 2.39B
Trailing P/E (ttm) 27.77
Forward P/E 6.76
PEG ratio 0.06
Price/Sales (ttm) 0.83
Price/Book (mrq) 1.2
Enterprise Value/Revenue 1.09
Enterprise Value/EBITDA 19.13

Overview

Shares outstanding 104.96M
Float 91.78M
Shares short 25.33M
% Held by insiders 0.05%
% Held by institutions 0.9%
Average volume (10 days) 2.96M
Average volume (90 days) 3.42M

Price summary

52-Week low 10.42
52-Week high 25.32
Beta 0.28
50-Day moving average 17.25
200-Day moving average 19.51

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:6
Last split Date 12 Jul 2012

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025

Profitability

Profit margin 0.03%
Operating margin -0.02%

Operational effectiveness

Return on assets 0.02%
Return on equity 0.05%

Income Statement

Revenue (ttm) 2.2B
Revenue per share (ttm) 20.8
Quarterly revenue growth (yoy) -0.33%
Gross profit (ttm) -163.43M
EBITDA -613.25M
Net income to common (ttm) -713.41M
Diluted EPS (ttm) 0.62
Quarterly earnings growth (yoy) -0.33%

Balance Sheet

Total cash (mrq) 939.65M
Total cash per share (mrq) 6.22
Total debt (mrq) 1.04B
Total Debt/Equity (mrq) 0.69
Current ratio (mrq) 4.63%
Book value per share (mrq) 14.34

Cash Flow

Cash flow statement -205.48M
Levered free cash flow (LFCF) 95.92M